CY1111750T1 - Νευροτροφικοι παραγοντες - Google Patents
Νευροτροφικοι παραγοντεςInfo
- Publication number
- CY1111750T1 CY1111750T1 CY20111100765T CY111100765T CY1111750T1 CY 1111750 T1 CY1111750 T1 CY 1111750T1 CY 20111100765 T CY20111100765 T CY 20111100765T CY 111100765 T CY111100765 T CY 111100765T CY 1111750 T1 CY1111750 T1 CY 1111750T1
- Authority
- CY
- Cyprus
- Prior art keywords
- neurotrophic factors
- neublastin
- polypeptides
- methods
- antibodies
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title 1
- 102000007072 Nerve Growth Factors Human genes 0.000 title 1
- 239000003900 neurotrophic factor Substances 0.000 title 1
- 102100026376 Artemin Human genes 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/804,615 US20020055467A1 (en) | 1998-07-06 | 2001-03-12 | Novel neurotrophic factors |
| EP07120461A EP1930439B1 (en) | 2001-03-12 | 2002-03-12 | Neurotrophic factors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111750T1 true CY1111750T1 (el) | 2015-10-07 |
Family
ID=25189406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100765T CY1111750T1 (el) | 2001-03-12 | 2011-08-10 | Νευροτροφικοι παραγοντες |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020055467A1 (https=) |
| EP (2) | EP1373503B1 (https=) |
| JP (2) | JP3738008B2 (https=) |
| CN (1) | CN1268744C (https=) |
| AT (2) | ATE509103T1 (https=) |
| AU (1) | AU2002240943B2 (https=) |
| CA (1) | CA2440767C (https=) |
| CY (1) | CY1111750T1 (https=) |
| DE (1) | DE60223511T2 (https=) |
| DK (2) | DK1930439T3 (https=) |
| ES (2) | ES2366610T3 (https=) |
| NZ (1) | NZ528790A (https=) |
| PT (2) | PT1373503E (https=) |
| SI (2) | SI1930439T1 (https=) |
| WO (1) | WO2002072826A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| HK1045528B (zh) * | 1998-07-14 | 2006-10-27 | 詹森药业有限公司 | 神经营养生长因子 |
| NZ526610A (en) * | 2000-12-22 | 2009-08-28 | Genentech Inc | New use of artemin, a member of the GDNF ligand family |
| US7442370B2 (en) * | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
| US7276580B2 (en) * | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
| CN1525866B (zh) * | 2001-03-28 | 2013-05-29 | 比奥根艾迪克Ma公司 | 神经胚活素多肽的治疗作用 |
| EP1463530A4 (en) * | 2001-12-19 | 2006-09-06 | Lijun Wang | ADENO-ASSOCIATED VIRUS-RELATED DELIVERY OF GDNF TO SKELETAL MUSCLES |
| JP4571776B2 (ja) * | 2002-11-05 | 2010-10-27 | Ｊｘ日鉱日石エネルギー株式会社 | 潤滑油組成物 |
| EA008743B1 (ru) * | 2003-01-31 | 2007-08-31 | Байоджен Айдек Ма Инк. | Полимерные конъюгаты мутантного неубластина |
| WO2004094592A2 (en) * | 2003-04-18 | 2004-11-04 | Biogen Idec Ma Inc. | Polymer-conjugated glycosylated neublastin |
| NZ544263A (en) | 2003-06-10 | 2009-04-30 | Nsgene As | Improved secretion of neublastin |
| US7598059B2 (en) * | 2003-10-02 | 2009-10-06 | Biogen Idec Ma Inc. | Neublastin expression constructs |
| BRPI0415563A (pt) | 2003-10-20 | 2007-01-02 | Nsgene As | método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional |
| DK1786454T3 (da) * | 2004-08-19 | 2010-09-06 | Biogen Idec Inc | Neublastinvarianter |
| CA2577690C (en) * | 2004-08-19 | 2013-08-06 | Biogen Idec Ma Inc. | Refolding transforming growth factor beta family proteins |
| US20080260702A1 (en) * | 2005-10-11 | 2008-10-23 | Jesper Roland Jorgensen | Treatment of Retinopathies Using Gfra3 Agonists |
| TWI501774B (zh) * | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
| ES2450065T3 (es) * | 2006-03-01 | 2014-03-21 | Biogen Idec Ma Inc. | Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF |
| EP2142205B1 (en) | 2007-05-01 | 2014-04-02 | Biogen Idec MA Inc. | Neublastin peptides for use in increasing vascularisation in tissue with impaired blood flow |
| WO2009020964A2 (en) * | 2007-08-08 | 2009-02-12 | Biogen Idec Ma Inc. | Anti-neublastin antibodies and uses thereof |
| US20100247437A1 (en) * | 2007-10-01 | 2010-09-30 | Vgx Pharmaceuticals, Llc | Materials and methods for the delivery of biomolecules to cells of an organ |
| WO2012041328A1 (en) * | 2010-10-01 | 2012-04-05 | Nsgene A/S | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| KR20200144576A (ko) * | 2018-05-17 | 2020-12-29 | 주식회사 헬릭스미스 | 화학요법-유발 말초신경병증과 관련된 신경병증성 통증의 치료 |
| WO2022244757A1 (ja) | 2021-05-18 | 2022-11-24 | 株式会社Ｌｔｔバイオファーマ | 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184200B1 (en) * | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
| CN1163509C (zh) | 1996-05-08 | 2004-08-25 | 拜奥根有限公司 | 刺激神经和肾生长的RET配体(RetL) |
| WO2000073348A2 (en) * | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| US6284540B1 (en) * | 1998-09-29 | 2001-09-04 | Washington University | Artemin, a novel neurotrophic factor |
| WO2000034475A2 (en) * | 1998-12-09 | 2000-06-15 | Amgen Inc. | Grnf4, a gdnf-related neurotrophic factor |
-
2001
- 2001-03-12 US US09/804,615 patent/US20020055467A1/en not_active Abandoned
-
2002
- 2002-03-12 ES ES07120461T patent/ES2366610T3/es not_active Expired - Lifetime
- 2002-03-12 JP JP2002571881A patent/JP3738008B2/ja not_active Expired - Fee Related
- 2002-03-12 NZ NZ528790A patent/NZ528790A/en not_active IP Right Cessation
- 2002-03-12 WO PCT/EP2002/002691 patent/WO2002072826A2/en not_active Ceased
- 2002-03-12 DE DE60223511T patent/DE60223511T2/de not_active Expired - Lifetime
- 2002-03-12 AT AT07120461T patent/ATE509103T1/de active
- 2002-03-12 EP EP02706759A patent/EP1373503B1/en not_active Expired - Lifetime
- 2002-03-12 AT AT02706759T patent/ATE378353T1/de active
- 2002-03-12 DK DK07120461.4T patent/DK1930439T3/da active
- 2002-03-12 PT PT02706759T patent/PT1373503E/pt unknown
- 2002-03-12 SI SI200230954T patent/SI1930439T1/sl unknown
- 2002-03-12 CN CNB028097858A patent/CN1268744C/zh not_active Expired - Fee Related
- 2002-03-12 PT PT07120461T patent/PT1930439E/pt unknown
- 2002-03-12 EP EP07120461A patent/EP1930439B1/en not_active Expired - Lifetime
- 2002-03-12 SI SI200230656T patent/SI1373503T1/sl unknown
- 2002-03-12 ES ES02706759T patent/ES2296899T3/es not_active Expired - Lifetime
- 2002-03-12 DK DK02706759T patent/DK1373503T3/da active
- 2002-03-12 AU AU2002240943A patent/AU2002240943B2/en not_active Ceased
- 2002-03-12 CA CA2440767A patent/CA2440767C/en not_active Expired - Fee Related
-
2005
- 2005-02-02 JP JP2005027109A patent/JP2005198656A/ja not_active Withdrawn
-
2011
- 2011-08-10 CY CY20111100765T patent/CY1111750T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60223511D1 (de) | 2007-12-27 |
| EP1930439A1 (en) | 2008-06-11 |
| ES2366610T3 (es) | 2011-10-21 |
| CA2440767A1 (en) | 2002-09-19 |
| JP2005198656A (ja) | 2005-07-28 |
| PT1930439E (pt) | 2011-07-25 |
| JP2004531242A (ja) | 2004-10-14 |
| HK1120556A1 (en) | 2009-04-03 |
| DK1373503T3 (da) | 2008-03-25 |
| DK1930439T3 (da) | 2011-08-29 |
| CN1268744C (zh) | 2006-08-09 |
| WO2002072826A2 (en) | 2002-09-19 |
| EP1373503B1 (en) | 2007-11-14 |
| WO2002072826A3 (en) | 2003-04-10 |
| AU2002240943B2 (en) | 2007-05-10 |
| EP1373503A2 (en) | 2004-01-02 |
| EP1930439B1 (en) | 2011-05-11 |
| PT1373503E (pt) | 2008-02-26 |
| SI1930439T1 (sl) | 2011-09-30 |
| CA2440767C (en) | 2012-05-29 |
| NZ528790A (en) | 2004-06-25 |
| SI1373503T1 (sl) | 2008-04-30 |
| ATE378353T1 (de) | 2007-11-15 |
| ES2296899T3 (es) | 2008-05-01 |
| CN1509333A (zh) | 2004-06-30 |
| AU2002240943A2 (en) | 2002-09-24 |
| US20020055467A1 (en) | 2002-05-09 |
| DE60223511T2 (de) | 2008-10-23 |
| ATE509103T1 (de) | 2011-05-15 |
| JP3738008B2 (ja) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111750T1 (el) | Νευροτροφικοι παραγοντες | |
| ATE522609T1 (de) | Neurotrophe faktoren | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| ATE411082T1 (de) | Neue verwendung von kurzkettigen carbonsäuren | |
| PT1015585E (pt) | Homologos de ligandos de tie | |
| BR0012759A (pt) | Neurotoxinas recombinantes ativáveis | |
| EA200400510A1 (ru) | Агенты, специфически связывающие ангиопоэтин-2 | |
| NO20054836L (no) | Nogo-reseptorbindingsprotein | |
| DE60227718D1 (de) | Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen | |
| ATE390482T1 (de) | Interleukin-1 hy2. mittel und verfahren | |
| ATE309356T1 (de) | Konstruierte fluoreszenzproteine mit langen wellenlängen | |
| EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
| WO2007045019A3 (en) | Polyoleosins | |
| EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
| DE60200162D1 (de) | Härtungszusammensetzung | |
| WO2003025134A3 (en) | mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF | |
| EA200100110A1 (ru) | Нейротрофические факторы | |
| DE60211227D1 (de) | Androgenrezeptor-Komplex assoziiertes Protein | |
| NO20033452D0 (no) | Polynukleotid konstrukter for ökt lysin produksjon | |
| DE60217720D1 (de) | Kurkumin-zusammensetzung zur heilung von dickdarmpolypen |